PD Dr. Martin Bachmann

  • Dr. Martin Bachmann, PhD in molecular biology, has been Executive Vice President and Chief Scientific Officer of Cytos Biotechnology since October 1999 until 2011. He is currently appointed at the University of Zürich and serves as a member of the Scientific Advisory Board of several companies. He received his PhD in 1995 at the Institute for Experimental Immunology, Zurich, in the laboratories of Nobel Laureate Prof. Zinkernagel and Prof. Hengartner. In 2005, he received a teaching position (Venia Legendi) for Immunology from the University of Zurich. He is author of more than 200 articles in internationally renowned scientific journals. His achievements were honoured with two ETH Medals (1991 and 1995), the Pfizer Prize for Immunology (1998), and the Swiss Technology Award (2004).

Back to overview

Latest News

  • 21 January 2019

    Malcisbo has been selected as emerging company to present at the Animal Health Investment Forum in London (Feb 2019)

  • 26 November 2018

    VetBioNet grant

    Malcisbo wins a grant to perform an APP challenge trial in a BLS3 facility.

  • 25 January 2017

    Malcisbo has been selected as emerging company to present at the Animal Health Investment Forum in London (Feb 2017)